Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity
出版年份 2023 全文链接
标题
Endocannabinoid-related molecules predict the metabolic efficacy of GLP-1 receptor agonism in humans with obesity
作者
关键词
-
出版物
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-04
DOI
10.1007/s40618-023-02228-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Palmitoylethanolamide dampens neuroinflammation and anxiety-like behavior in obese mice
- (2022) Adriano Lama et al. BRAIN BEHAVIOR AND IMMUNITY
- Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities
- (2022) Elliot D. Mock et al. PROGRESS IN LIPID RESEARCH
- Healthy Weight Loss Maintenance with Exercise, Liraglutide, or Both Combined
- (2021) Julie R. Lundgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Roles of Endocannabinoids and Endocannabinoid-like Molecules in Energy Homeostasis and Metabolic Regulation: A Nutritional Perspective
- (2021) S.M. Khaledur Rahman et al. Annual Review of Nutrition
- The L‐α‐lysophosphatidylinositol/GPR55 system induces the development of non‐alcoholic steatosis and steatohepatitis
- (2020) Marcos F. Fondevila et al. HEPATOLOGY
- Intestinal NAPE-PLD contributes to short-term regulation of food intake via gut to brain axis
- (2020) Marialetizia Rastelli et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists
- (2019) Rasmus M. Christensen et al. DRUG SAFETY
- Weight loss variability with SGLT2 inhibitors and GLP‐1 receptor agonists in type 2 diabetes mellitus and obesity: Mechanistic possibilities
- (2019) Emily Brown et al. Obesity Reviews
- Oleoylethanolamide modulates glucagon-like peptide-1 receptor agonist signaling and enhances Exendin-4-mediated weight loss in obese mice
- (2018) Jacob D Brown et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial
- (2018) Richard E Pratley et al. Lancet Diabetes & Endocrinology
- Profiling plasma N-Acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism
- (2018) Flaminia Fanelli et al. Molecular Metabolism
- Modulation of Glucagon-like Peptide-1 (GLP-1) Potency by Endocannabinoid-like Lipids Represents a Novel Mode of Regulating GLP-1 Receptor Signaling
- (2015) Yu-Hong Cheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Palmitoylethanolamide Prevents Metabolic Alterations and Restores Leptin Sensitivity in Ovariectomized Rats
- (2014) G. Mattace Raso et al. ENDOCRINOLOGY
- Treatment with a GLP-1 receptor agonist diminishes the decrease in free plasma leptin during maintenance of weight loss
- (2014) E W Iepsen et al. INTERNATIONAL JOURNAL OF OBESITY
- Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways
- (2011) H Lan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis
- (2011) Liqun Ma et al. CARDIOVASCULAR RESEARCH
- Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity
- (2011) B Gatta-Cherifi et al. INTERNATIONAL JOURNAL OF OBESITY
- GPR119 Is Essential for Oleoylethanolamide-Induced Glucagon-Like Peptide-1 Secretion From the Intestinal Enteroendocrine L-Cell
- (2009) L. M. Lauffer et al. DIABETES
- Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects
- (2009) Vincenzo Di Marzo et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now